ストックスクリーナーアプリを入手
0.70
2.15%
0.0147
前日終値:
$0.6853
開ける：
$0.6701
24時間の取引高:
166.59K
Relative Volume:
0.25
時価総額：
$53.82M
収益：
$222.00K
当期純損益:
$-22.92M
株価収益率:
-0.4861
EPS:
-1.44
ネットキャッシュフロー:
$-15.47M
1週間 パフォーマンス:
-2.45%
1か月 パフォーマンス:
+21.70%
6か月 パフォーマンス:
-48.15%
1年 パフォーマンス:
-46.56%
1日の値動き範囲:
$0.66
$0.7289
1週間の範囲:
$0.66
$0.73
52週間の値動き範囲:
$0.3625
$1.91
Envoy Medical Inc Stock (COCH) Company Profile
名前
Envoy Medical Inc
セクター
電話
651-361-8000
住所
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.70 | 52.69M | 222.00K | -22.92M | -15.47M | -1.44 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-24 | 開始されました | Ascendiant Capital Markets | Buy |
Envoy Medical Inc (COCH) 最新ニュース
COCH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
COCH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Envoy Medical Regains Nasdaq Listing Compliance After Financing - TipRanks
Envoy Medical (NASDAQ: COCH) regains compliance with Nasdaq listing rule - Stock Titan
Revenue Check: Can Envoy Medical Inc Equity Warrant be the next market leaderQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Envoy Medical secures three new patents, bolstering cochlear implant leadership - Indian Pharma Post
Envoy Medical Nears Enrollment Completion for Acclaim Cochlear Implant Trial - The Hearing Review
Envoy Medical regains Nasdaq compliance after balance sheet work - Investing.com Australia
Envoy Medical (COCH) Price Target Increased by 15.15% to 9.69 - Nasdaq
Envoy Medical regains Nasdaq compliance after balance sheet work By Investing.com - Investing.com South Africa
COCHW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Envoy Medical Regains Compliance with Nasdaq Listing Requirement - TMX Newsfile
Nasdaq clears Envoy Medical after $35M value shortfall - Stock Titan
Envoy Medical receives three new patents for cochlear implant tech By Investing.com - Investing.com India
Envoy Medical receives three new patents for cochlear implant tech - Investing.com Australia
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - marketscreener.com
Three new patents detail Envoy’s fully implanted cochlear tech - Stock Titan
Does Envoy Medical Inc. stock benefit from AI growthTrade Analysis Summary & High Win Rate Trade Alerts - mfd.ru
What are analysts’ price targets for Envoy Medical Inc.July 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - The Globe and Mail
Envoy Medical raises $30 million, nears completion of cochlear implant trial By Investing.com - Investing.com South Africa
Analyzing Envoy Medical (NASDAQ:COCH) and TearLab (OTCMKTS:TEAR) - Defense World
Envoy Medical raises $30 million, nears completion of cochlear implant trial - Investing.com Nigeria
Fully implanted cochlear implant nears trial end as Envoy's $30M financing lands - Stock Titan
Glen Taylor Buys 241% More Envoy Medical Shares - simplywall.st
Envoy Medical interim CFO buys $85k in shares - Investing.com South Africa
Envoy Medical interim CFO buys $85k in shares By Investing.com - Investing.com Canada
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock - Investing.com
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock By Investing.com - Investing.com Australia
Envoy Medical (COCH) investor details 84.8% beneficial ownership stake - Stock Titan
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - marketscreener.com
Form 4: Lucas Brent T. reports purchase transactions in COCH - Stock Titan
Can Envoy Medical Inc. Equity Warrant continue delivering strong returnsMarket Growth Report & Capital Protection Trade Alerts - mfd.ru
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial - MSN
Envoy Medical Closes Upsized Public Offering to Fund Growth - TipRanks
Envoy Medical Signs Multiple Financing Agreements - TradingView
Is Envoy Medical Inc. Equity Warrant stock gaining market share2025 Dividend Review & Daily Profit Maximizing Tips - mfd.ru
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering - TradingView
Is Envoy Medical Inc. stock risky to hold now2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Envoy Medical Grants Stock Options to Key Executives - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering - TMX Newsfile
Envoy Medical announces pricing of up to $78M public offering - MSN
Envoy Medical (NASDAQ: COCH) gets 7.87% stake filing from Ayrton - Stock Titan
Hearing implant maker Envoy Medical raises $30M, eyes FDA-tied warrant cash - Stock Titan
Is Envoy Medical Inc. stock a dividend growth opportunityGap Down & Daily Growth Stock Tips - mfd.ru
Why Envoy Medical Inc. stock remains on buy lists2025 Support & Resistance & Daily Stock Trend Reports - mfd.ru
Envoy Medical Inc (COCH) 財務データ
収益
当期純利益
現金流量
EPS
Envoy Medical Inc (COCH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
| Patel Mona Chetan | Director |
Jun 11 '25 |
Buy |
1.47 |
2,500 |
3,675 |
20,000 |
| Patel Mona Chetan | Director |
Jun 06 '25 |
Buy |
1.46 |
10,000 |
14,600 |
17,500 |
| BRYNELSEN CHARLES | Director |
May 27 '25 |
Buy |
1.65 |
35,000 |
57,673 |
50,000 |
| BRYNELSEN CHARLES | Director |
May 23 '25 |
Buy |
1.64 |
13,000 |
21,363 |
15,000 |
| BRYNELSEN CHARLES | Director |
May 22 '25 |
Buy |
1.68 |
2,000 |
3,367 |
2,000 |
2.27%
1.94%
大文字化:
|
ボリューム (24 時間):